Voluntary Site of Service

 

The Voluntary Site of Service policy has been adopted as part of the Provider-administered Drug Review (PAD) Program. The primary objective of the Voluntary Site of Service program is to guide the administration of select drug infusions to the most economic and clinically appropriate place of treatment.  The member and the provider must agree to transition care to the alternate setting.

 

The physician must approve that the use of the alternative place of treatment is clincally appropriate for the member's infusion. All drugs included require precertificationthrough Magellan Rx. When required, the home infusion provider will obtain all necessary nursing precertifications as specificed by the member's benefits.